Can Sarısözen

1.7k citations
35 papers · 1.4k indexed · h-index 24

Can Sarısözen

34 papers receiving 1.4k citations

Peers

Can Sarısözen
Comparison fields: 5 of 100
  • Biomaterials 670
  • Pharmaceutical Science 188
  • Molecular Medicine 94
  • Biological Psychiatry 40
  • Molecular Biology 687
Replace Lilian E. van Vlerken with:
Lilian E. van Vlerken United States
Aditi Jhaveri United States
Jianqin Lu United States
Chaemin Lim South Korea
Linwei Lu China
Jianming Liang China
Cristina Fonseca Portugal
Liangjie Hong China
Anna Scomparin Israel
Tingting Meng China
Can Sarısözen relative to Lilian E. van Vlerken United States Lilian E. van Vlerken's profile →
Citations per field
00.5×
Lilian E. van Vlerken · 1×
Citations per year

Countries citing papers authored by Can Sarısözen

Since Specialization
Citations

This map shows the geographic impact of Can Sarısözen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Can Sarısözen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Can Sarısözen more than expected).

Fields of papers citing papers by Can Sarısözen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Can Sarısözen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Can Sarısözen. The network helps show where Can Sarısözen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Can Sarısözen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Can Sarısözen Line = papers co-authored together Can Sarısözen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 202029
3 202034
4 201982
5 20192
6 201716
7 201684
8 20166
9 201623
10 201527
11 201550
12 201447
13 2014124
14 201317
15 201244
16 201260
17 201126
18 201140
19 20107
20 20103

About Can Sarısözen

Can Sarısözen is a scholar working on Biomaterials, Pharmaceutical Science and Biological Psychiatry, having authored 35 papers that have together received 1.4k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (17 papers), RNA Interference and Gene Delivery (15 papers), Advanced biosensing and bioanalysis techniques (10 papers), Nanoplatforms for cancer theranostics (7 papers), Drug Transport and Resistance Mechanisms (5 papers), Dendrimers and Hyperbranched Polymers (4 papers), Drug Solubulity and Delivery Systems (3 papers) and Advanced Drug Delivery Systems (3 papers). The work is most often cited by research in Biomaterials (670 citations), Pharmaceutical Science (188 citations) and Molecular Medicine (94 citations). Can Sarısözen has collaborated with scholars based in United States, Türkiye and Saudi Arabia. Frequent co-authors include Vladimir P. Torchilin, Vladimir P. Torchilin, Abraham H. Abouzeid, Cemil Bilir, Ed Luther, İmran Vural, Shravan Kumar Sriraman, Jiayi Pan, Giuseppina Salzano and Lívia P. Mendes. Their work appears in journals such as SHILAP Revista de lepidopterología, Chemical Communications and Journal of Controlled Release.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026